Robert Jessica, Clauser Eacute Ric
Département d'Endocrinologie, Métabolisme et Cancer, Institut Cochin, INSERM U567, UMR 8104, CNRS, Université Paris V, Faculté de Médecine Cochin, 24, rue du Faubourg Saint-Jacques, 75014 Paris.
J Soc Biol. 2005;199(4):351-9. doi: 10.1051/jbio:2005037.
Vasopressin, a hypothalamic hormone, acts on its target tissues via three different G protein coupled receptors. The vasopressin V1a and V1b receptors, associated to Gq protein and phospholipase C, are responsible for vasoconstriction and regulation of the corticotroph axis respectively. The V2 vasopressin receptor is coupled to Gs protein and adenylyl cyclase and is responsible for water reabsorption in the renal collecting duct. Mutations of the V2 receptor are involved in diabetes insipidus and most of these mutations result in an endoplasmic reticulum (ER) retention of the mutated receptor. With the V1b receptor model, we have identified a proximal sequence of the C-terminal segment, which is crucial for ER export. Mutations in this short domain result in ER accumulation and degradation of the receptor. SSR 149415, a nonpeptide antagonist of V1bR, which is permeable to cell membrane, is able to rescue the mutant phenotype and acts as a pharmacological chaperone.
血管加压素是一种下丘脑激素,它通过三种不同的G蛋白偶联受体作用于其靶组织。与Gq蛋白和磷脂酶C相关的血管加压素V1a和V1b受体分别负责血管收缩和促肾上腺皮质激素轴的调节。血管加压素V2受体与Gs蛋白和腺苷酸环化酶偶联,负责肾集合管中的水重吸收。V2受体的突变与尿崩症有关,这些突变大多导致突变受体在内质网(ER)中滞留。通过V1b受体模型,我们确定了C末端片段的近端序列,这对ER输出至关重要。该短结构域中的突变导致受体在ER中积累和降解。SSR 149415是一种V1bR的非肽拮抗剂,可透过细胞膜,能够挽救突变表型并作为药理伴侣发挥作用。